CS191254B2 - Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza - Google Patents

Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza

Info

Publication number
CS191254B2
CS191254B2 CS75255A CS25575A CS191254B2 CS 191254 B2 CS191254 B2 CS 191254B2 CS 75255 A CS75255 A CS 75255A CS 25575 A CS25575 A CS 25575A CS 191254 B2 CS191254 B2 CS 191254B2
Authority
CS
Czechoslovakia
Prior art keywords
neuraminidazoic
hemagglutinic
isolation
component
virus influenza
Prior art date
Application number
CS75255A
Other languages
Czech (cs)
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS191254B2 publication Critical patent/CS191254B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
CS75255A 1974-01-14 1975-01-14 Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza CS191254B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
CS191254B2 true CS191254B2 (en) 1979-06-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
CS75255A CS191254B2 (en) 1974-01-14 1975-01-14 Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
ES2359214T5 (en) * 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Viral vaccines derived from cells with reduced levels of residual cellular DNA by treatment with beta-propiolactone
SI2192917T1 (en) * 2007-08-28 2014-05-30 Baxter International Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
FR2257305B1 (en) 1982-03-19
DD116239A5 (en) 1975-11-12
ZA75259B (en) 1976-08-25
AU500250B2 (en) 1979-05-17
IE40794L (en) 1975-07-14
JPS50100224A (en) 1975-08-08
NO143128B (en) 1980-09-15
NL166622C (en) 1981-09-15
NL166622B (en) 1981-04-15
DK1475A (en) 1975-09-01
FI750014A (en) 1975-07-15
IE40794B1 (en) 1979-08-15
SU616997A3 (en) 1978-07-25
SE427238B (en) 1983-03-21
NO750031L (en) 1975-08-11
JPS58407B2 (en) 1983-01-06
ATA21475A (en) 1978-01-15
HU173920B (en) 1979-09-28
DE2500785A1 (en) 1975-07-31
DE2500785B2 (en) 1980-01-03
SE7500130L (en) 1975-07-15
ES433759A1 (en) 1977-02-16
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
YU5875A (en) 1984-04-30
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
DE2500785C3 (en) 1980-09-11
FR2257305A1 (en) 1975-08-08
IL46426A0 (en) 1975-04-25
FI54053B (en) 1978-06-30
GB1498261A (en) 1978-01-18
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
DK140003B (en) 1979-06-05
CH589453A5 (en) 1977-07-15
CA1049406A (en) 1979-02-27
MY8100204A (en) 1981-12-31
NO143128C (en) 1980-12-29
IL46426A (en) 1978-01-31
FI54053C (en) 1978-10-10
JPS6035326B2 (en) 1985-08-14
NL7500301A (en) 1975-07-16
YU41289B (en) 1987-02-28
PL93689B1 (en) 1977-06-30
AT345449B (en) 1978-09-11

Similar Documents

Publication Publication Date Title
HU171420B (en) Process for preparing derivatives of the sulphonamide-pyridine and pyridine-thiadiazine
DK356075A (en) PROCEDURE FOR THE PREPARATION OF 1-OXACEPHEMES AND INTERMEDIATE PRODUCTS
SE419605B (en) PROCEDURE FOR THE PREPARATION OF THE REPRESSED FORM
IE41786L (en) Process for the preparation of ketones
ZA756397B (en) Process for the manufacture of cyclohexane-1,3-diones and 6-alkyl-3,4-dihydro-2-pyranones
CS191254B2 (en) Process for the isolation of hemagglutinic and neuraminidazoic component of virus influenza
ZA757118B (en) Process for the preparation of addition agents
ZA752394B (en) Process for the isolation of gama-l-glutamyl-taurine
EG11831A (en) Process for the preparation of 2-nitrobenzaldehyde and 2-nitrobenzylidenechloride
CH613683A5 (en) Process for the preparation of secoprostaglandins
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
EG11784A (en) Process for the preparation of octenitrile compounds and compounds obtained thereby
RO66137A (en) PROCESS FOR THE PREPARATION OF CARNITIVE CLORHIDRATE
ZA751970B (en) Process for the preparation of 2-nitrobenzaldehyde
ZA752148B (en) Process and equipment for the condensation of steam
IL47849A (en) Process for the preparation of poly-(-n-alkyliminoalanes)
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
ZA75976B (en) Process for the preparation of cis-vincamine
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
NO143224C (en) PROCEDURE FOR THE PREPARATION OF HYDROXYALKYLXANTHINES
CH614216A5 (en) Process for the preparation of deoxyparomomycin and dideoxyparomomycin
GB1485916A (en) Process for the preparation of propargyl amines and products obtained thereby
ZA755816B (en) Thiamindisulphide-orotate and process for its preparation
IL48633A0 (en) Process for the preparation of trichlorothiazole
CH613693A5 (en) Process for the preparation of trisaminopyridines